Analysing the levels of ALKBHs in HNSCC tumours, we observed the simultaneous increase in expression of at least four ALKBH proteins in approx. 88% of patients and at least five ALKBHs in over 50% of patients. This evidence concerns the gene ALKBH1 and neoplasm.